Abstract
A series of 24 novel triazole-linked flavonol glycoconjugates 1~24 were synthesized using flavonols (Kaempferol, Rhamnocitrin or 7,5,4’-trimethoxy flavonol) and carbohydrates (glucose, galactose, lactose or maltose) as starting materials by a “Click chemistry” approach. Intermolecular Cu (I) catalyzed 1,3-dipolar cycloaddition of propargyl ethers of flavonols and glycosyl azides is the key step. Their cytotoxic potential against four human cancer cell lines (HL- 60, SMMC-7721, A-549 and MCF-7) was evaluated by standard MTT method. The results showed that 1, 3, 5, 6, 12 and 13 exhibit moderate to potent cytotoxicity against these cancer cell lines comparable with the positive control, cis- Platinum (DDP).
Keywords: Cytotoxic activity, Click chemistry, Flavonol, Glycoconjugates.
Letters in Organic Chemistry
Title:A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Volume: 10 Issue: 9
Author(s): Wu Zheng, Nguyen Van-son, Liu Zhang-kun and Wang Qiu-an
Affiliation:
Keywords: Cytotoxic activity, Click chemistry, Flavonol, Glycoconjugates.
Abstract: A series of 24 novel triazole-linked flavonol glycoconjugates 1~24 were synthesized using flavonols (Kaempferol, Rhamnocitrin or 7,5,4’-trimethoxy flavonol) and carbohydrates (glucose, galactose, lactose or maltose) as starting materials by a “Click chemistry” approach. Intermolecular Cu (I) catalyzed 1,3-dipolar cycloaddition of propargyl ethers of flavonols and glycosyl azides is the key step. Their cytotoxic potential against four human cancer cell lines (HL- 60, SMMC-7721, A-549 and MCF-7) was evaluated by standard MTT method. The results showed that 1, 3, 5, 6, 12 and 13 exhibit moderate to potent cytotoxicity against these cancer cell lines comparable with the positive control, cis- Platinum (DDP).
Export Options
About this article
Cite this article as:
Zheng Wu, Van-son Nguyen, Zhang-kun Liu and Qiu-an Wang, A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity, Letters in Organic Chemistry 2013; 10 (9) . https://dx.doi.org/10.2174/15701786113109990039
DOI https://dx.doi.org/10.2174/15701786113109990039 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Involvement of Hypoxia-Inducible Factors in the Dysregulation of Oxygen Homeostasis in Sepsis
Cardiovascular & Hematological Disorders-Drug Targets Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises
Cardiovascular & Hematological Agents in Medicinal Chemistry Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Re-Wiring the Circuit: Mitochondria as a Pharmacological Target in Liver Disease
Current Medicinal Chemistry Matrix Metalloproteinases
Current Medicinal Chemistry Cardioprotection by Regular Ethanol Consumption: Potential Mechanisms and Clinical Application
Current Drug Abuse Reviews Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology Extracts and Flavonoids of <i>Passiflora</i> Species as Promising Anti-inflammatory and Antioxidant Substances
Current Pharmaceutical Design Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases
Current Pharmaceutical Design Identification of Novel Key Targets and Candidate Drugs in Oral Squamous Cell Carcinoma
Current Bioinformatics Effect of the NMDA-Receptor Antagonist Dextromethorphan in Infant Rat Pneumococcal Meningitis
Current Drug Metabolism Ruthenium as an Effective Nitric Oxide Scavenger
Current Topics in Medicinal Chemistry Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases
Recent Patents on Biomarkers Phytochemicals: Potential in Management of Climacteric Neurobiology
Current Pharmaceutical Design Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Mitochondrial Dynamics: An Emerging Paradigm in Ischemia-Reperfusion Injury
Current Pharmaceutical Design Functional Renal MRI
Current Medical Imaging Future Treatment for COPD: Targeting Oxidative Stress and its Related Signal
Recent Patents on Inflammation & Allergy Drug Discovery